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The HNK-1 monoclonal antibody raised to the HSB-2 T  cell line detects Leu- 
7 antigen expressed on a  peripheral blood subpopulation of ---15% of lympho- 
cytes that comprises almost all the natural killer (NK) and killer (K) cells but no 
other blood cell (1).  Besides Leu-7, virtually all these cells carry either T  cell- 
associated markers or the M 1 antigen associated with monocytes and granulocytes 
(2).  The biochemical characterization of Leu-7 has not been published, except 
for its Mr of "~ 1 10,000  (L. Lanier, personal communication cited in 3). 
The distribution of Leu-7 has been studied in lymphoid organs by immuno- 
peroxidase staining of frozen sections of spleen, tonsils, and lymph nodes where 
it has been specifically located within the germinal centers, while in the thymus 
few scattered cells were identified as HNK-1 positive (4). In bone marrow, 0.2- 
1.2% Leu-7-positive cells were detected in total nucleated cells (1). The presence 
of HNK-l-positive  cells  in  nonhematopoietic  organs  has  not been  looked  for 
except for the infiltration of Leu-7-positive lymphocytes in a few tumors (5). 
Because  we  found the  same  distribution  of Leu-7-positive cells  on  paraffin 
sections of normal lymphoid tissues as that previously observed on frozen sections, 
we were able to investigate the reactivity with HNK-1  of various normal tissues 
and  tumors  embedded  in  paraffin.  The  results  we present  here  indicate that 
besides a  discrete population of lymphocytes, the HNK-1  antibody also detects 
an antigen specifically associated with tissues of neuroectodermal origin. 
Materials and Methods 
Cell Lines.  Human tumor-derived cell lines (Table I) were carried in RPMI 1640 with 
10% heat-inactivated fetal calf serum. Lines MDA-MB231, MCF-7,  M29, and IGR3 were 
donated by Dr.J.K. Youn; lines KB, MS.Rb, SA4, IMR32, and NJB by Dr.J. Belehradek; 
and lines HT29 and HRT18 by Dr. B. Fertil, all of the Institut G. Roussy. The placental 
choriocarcinoma BeWo originated from Dr. H. Sussman, and lines HT1080C and HelaS3 
from Dr.  Douglas Wallace, both of Stanford University, CA. Ewing's sarcoma (ES) cell 
lines IARC-EW1, IARC-EW3, IARC-EW7, and IARC-EW11, and the medulloblastoma 
cell line IARC-186 were derived and made available to us by Dr. G. Lenoir, I.A.R.C., 
Lyon, France and  Drs.  I.  Philip and  T.  Philip,  Centre  L~on  B~rard,  Lyon, France. 
Adherent cells were suspended using trypsin (1:250, 0.05%)-EDTA (0.02%) (Flow Labo- 
ratories, United Kingdom). 
HNK-1 Monoclonal Antibody.  The HNK-1 hybridoma was purchased from the Ameri- 
can  Type  Culture  Collection,  Rockville,  MD  and  grown  in  RPMI  with  10%  heat- 
inactivated horse serum. 
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Indirect hnmunofluorescence  Assays.  Cells were incubated with HNK-1 hydridoma super- 
natant  (5  x  l0 b cells  in  50  ul;  4°C,  45  min),  washed  three  times,  incubated  with 
fluoresceinated goat anti-mouse IgM (Tago Inc., Burlingame, CA) at appropriate dilution 
(1:25  in 50 ul RPMI; 4  °C, 45 min), washed three times, resuspended into 20 ~1 RPMI, 
smeared on slides, and live-examined for fluorescence under a Leitz Ortholux microscope 
(E  Leitz,  Inc.,  Rockleigh,  N  J)  equipped  with  the  proper  combination  of filters  for 
fluorescein fluorescence. Lines were scored positive  when >10%  of the live cells were 
fluorescent. Each set of experiments included a negative control with cells incubated in 
RPMI alone as the first step. 
hnmunoperoxidase Staining of Paraffin-embedded Tissues.  Histological sections (3 t~m) of 
paraffin-embedded tumors  or  normal  tissues  fixed in  alcohol-formalin-acetic acid  or 
Bouin's fixative were deparaffinized and rehydrated through xylene and graded alcohol 
series.  Nonspecific reactions were blocked by covering the slides with a  normal rabbit 
serum.  Sections  were  incubated  in  HNK-1  supernatant  (30  min,  20°C),  washed  in 
phosphate-buffered saline (PBS), pH  7.6 (10 rain),  then incubated with a  dilution of a 
rabbit anti-mouse Ig antiserum (1:100,  30 min, 20°C) conjugated to peroxidase. After 
washing 10 min in PBS, the reaction was revealed by diaminobenzidine-H~O2 incubation 
(10 min). Sections were counterstained with hematoxylin. Negative controls (first antibody 
omitted or irrelevant first antibody) were included in every set of experiments. 
Results and Discussion 
The  reactivity  of  the  HNK-1  antibody  was  checked  on  peripheral  blood 
mononuclear cells isolated from three normal donors. Between 12.8 and 14% of 
total cells were stained. After enrichment for large granular lymphocytes on a 
Percoll gradient, the percentage of positive cells increased to 34-43%. 
A  series of human tumor-derived cell  lines of nonhematopoietic origin  was 
tested by indirect immunofluorescence for HNK-1  reactivity. Results shown in 
Table  I  indicate  that  the  cell  lines  derived  from  tumors  of neuroectodermal 
origin were positive. These included two neuroblastomas, one medulloblastoma, 
one retinoblastoma, and two melanomas. Carcinomas, with the exception of the 
choriocarcinoma-derived BeWo, were all negative, as were sarcomas, except for 
three of four ES, which were positive. These data thus suggested that HNK-1 
might react with an antigen related to neuroectodermal differentiation. 
Our  observations  of paraffin-embedded  lymphoid tissues  from  normal  gas- 
trointestinal tract and lymph nodes stained with HNK-1  were  similar to those 
published on frozen sections (4).  We could analyze the presence or absence of 
Leu-7  on  specimens  of normal  and  pathologic  tissues  embedded  in  paraffin. 
Results obtained on tumor sections (Table II) correlate with data obtained with 
tumor  lines.  Most  malignancies  (24  of 30)  derived  from  neuroectoderm,  of 
neural tube and neural crest origin, were positive. The former included astro- 
cytoma,  glioblastoma,  retinoblastoma,  and  oligodendroglioma,  while  neural 
crest-derived tumors,  such as neuroblastoma,  paraganglioma, esthesioneurocy- 
toma, neuroepithelioma, phaeochromocytoma, and carcinoid tumors, were also 
stained  by  HNK-1;  one  of four  paragangliomas  and  one  thyroid  medullary 
cancer, however, were negative. Of three nerve sheath tumors probably derived 
from neural crest, one neurofibroma was positive, while one neurinoma and one 
neurogenic  sarcoma  were  negative.  Finally,  one  benign  naevus and  one  of 
two melanomas' were stained by HNK-1. Of the other tumors, including sarco- 
mas, carcinomas, ieukemias, and lymphomas, only three ES of six were HNK-1 
positive. 
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TABLE  I 
HNK-I: Reactivity with Nonhematopoietic Tumor Lines* 
Cell type  Embryologic origin  Name  Results 
Neuroblastoma  Neuroectoderm  IMR 32  + 
NJB  + 
Medulloblastoma  Neuroectoderm  IARC-186  + 
Retinoblastoma  MS.Rb  + 
Melanoma  M29  + 
IGR3  + 
Ewing's sarcoma  Unknown  IARC-EW1  + 
IARC-EW3  + 
IARC-EW7 
IARC-EW11  + 
Fibrosarcoma  Mesoderm  HT 1080C 
Liposarcoma  SA4 
Cervix adenocarcinoma  Hela $3 
m 
Oral epidermoid carcinoma  Ectoderm  KB 
Breast carcinoma  MCF7 
MDA-MB231 
m 
Rectum carcinoma  Endoderm  HRT 18 
Colon carcinoma  HT29 
Choriocarcinoma  Trophoblast  BeWo  + 
* Using indirect fluorescence microscopy. 
TABLE II 
HNK- I : Reactivity on Paraffin-embedded Tumors* 
Embryologic origin  Number tested  Number positive 
Neuroectoderm  30  24 
Mesoderm  12  0 
Ectoderm  3  0 
Germ cell  1  0 
Ewing's sarcoma  6  3 
* Using indirect immunoperoxidase technique. 
with  HNK-1  reacting  with a  differentiation  antigen  associated with neuroecto- 
dermal tissues. Nerve sheath cells were positive. In the adrenal, the neural crest- 
derived medulla,  where phaeochromocytoma originates,  but not the cortex,  of 
mesenchymal  origin,  was  strongly  stained  (Fig.  1 A).  In  the  appendix,  entero- 
chromaffin cells  were  the  only positive cells (Fig.  1 B).  All  other  tissues  tested 
were  negative,  including  epithelial  elements  of ectodermal  origin  (epidermis, 
sweat,  and  sebaceous glands,  respiratory epithelium  of nasal  cavity),  the  endo- 
derm-derived lung and  pancreas,  connective tissues of mesodermal derivation, 
kidney, and all testis cells including  Leydig, Sertoli, and germ cells. 
It appears that the specificity of HNK-1 is not restricted to the lymphoid subset 
known  to  carry  the  Leu-7  antigen,  but  that  HNK-I  also  specifically  stains  a 
variety of cells with a common derivation from the neuroectoderm. Nevertheless, 
a  few discrepancies  within  this  pattern  were  noted.  One  choriocarcinoma  cell 
line was stained  by HNK-1. Choriocarcinomas arise form trophoblasts and are 1778  LIPINSKI  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGURE  1.  Immunoperoxidase  staining of neuroectoderm-derived tissues with HNK-1  hy- 
bridoma supernatant  followed by goat anti-mouse  IgM antiserum  conjugated to peroxidase 
and  revealed by diaminobenzidine.  In the adrenal  (A), medullary but  not cortical cells are 
HNK-1 +. In the appendix (B), only enterochromaffin cells are HNK-1 +. LIPINSKI ET  AL.  BRIEF  DEFINITIVE REPORT  1779 
therefore  likely  to  express  surface  antigens  that  can  be  detected  on  various 
tissues. Also, three of four ES cell lines, as well as three of six ES sections, were 
detected by HNK-1. The  histogenesis of this bone tumor remains a  matter of 
debate  (6,  7);  differential  diagnosis  is  sometimes  difficult as  between  ES and 
neuroblastoma.  The  observation  that  a  percentage  of ES  were  positive  with 
HNK-1 could indicate a heterogeneity of derivation within the group of ES. We 
here suggest that HNK-l-positive ES could indeed derive from neuroectoderm. 
In  man,  several antigens  are  shared  by neuroectoderm-derived  tumors and 
hematopoietic cells. Common acute lymphoblastic antigen  (CALLA), first asso- 
ciated with acute lymphoblastic leukemia  (8),  has been detected on glioma (9) 
and  melanoma  (10)  lines and  normal  kidney (11).  Another  leukemia  antigen, 
defined by antibody BA2, reacts with some neuroblastomas and melanomas (12). 
HLA class II antigens on B lymphocytes, monocytes, and macrophage-type cells 
are  also  expressed  on  neuroectodermai  tumors  such  as  melanomas  (13,  14). 
UCHT 1 and Leu-4 monoclonal antibodies that react with all T  cells specifically 
detect  Purkinje  cells in  the  central  nervous  system (15).  By contrast,  recently 
described  antibodies  directed  to  neuroectodermal  antigens  do  not  stain  any 
blood cell (16, 17). Antibodies 7.51 and 7.60, directed to antigens on melanoma, 
neuroblastoma, retinoblastoma, and glioma, but not on lymphoma and leukemia 
lines, have not been reported to react with normal hematopoietic cells (18). 
This paper thus constitutes the first report, to our knowledge, of a cell surface 
antigen present on a discrete peripheral  blood lymphocyte subset with NK and 
K  cell activities,  and  shared  by most neuroectoderm-derived  tissues.  Whether 
HNK-1  is directed to truly identical  antigens on both lineages or rather  reacts 
with the same or cross-reacting epitopes on distinct structures on [ymphocytes 
and neuroectodermal cells remains to be elucidated. 
Because the HNK-l-defined neuroectodermal antigen is not destroyed during 
paraffin inclusion, the HNK-1 antibody could be of considerable clinical interest 
in histopathology, provided that  its tissue distribution,  much wider than  previ- 
ously believed, is recognized. Our observation, along with similar ones on other 
antibodies (9-11), further emphasizes that the increasing number of monoclonal 
antibodies reported should be carefully screened on hematopoietic and nonhe- 
matopoietic tissues before they can be presented as specific for any one cell type. 
Summary 
The HNK-1 antibody known to define a subpopulation of human lymphocytes 
with  natural  killer  and  killer  cell  activities  was  shown  to  detect  a  common 
neuroectodermal antigen.  Most tumor lines and paraffin-embedded tumors and 
normal  tissues of neuroectodermal  origin  were specifically stained  by HNK-1. 
Lines and tissues of other derivations were negative except a trophoblastic tumor 
line and a  percentage of Ewing's sarcomas, whose histogenesis is poorly under- 
stood. These data indicate that  HNK-1 antibody could be of interest in clinical 
histopathology but cannot be considered as specific for a lymphocyte subset. 
Received  for publication 18July 1983. 
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